Press releases View full list

February 14, 2023

Invitae to Announce Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 28, 2023

SAN FRANCISCO, Feb. 14, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it will report its fourth quarter and full year 2022 financial results on Tuesday, February 28, 2023, and will host a conference call and webcast that day at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and recent highlights.

To access the conference call, please register at the link below:
https://www.netroadshow.com/events/login?show=d75171b5&confId=46549 

Upon registering, each participant will be provided with call details and access codes.

The live webcast of the call and slide deck may be accessed here or by visiting the investors section of the company's website at ir.invitae.com. A replay of the webcast will be available shortly after the conclusion of the call and will be archived on the company's website.

About Invitae

Invitae (NYSE: NVTA) is a leading medical genetics company trusted by millions of patients and their providers to deliver timely genetic information using digital technology. We aim to provide accurate and actionable answers to strengthen medical decision-making for individuals and their families. Invitae's genetics experts apply a rigorous approach to data and research, serving as the foundation of their mission to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.

To learn more, visit invitae.com and follow for updates on TwitterInstagramFacebook and LinkedIn @Invitae.

Contacts:

Hoki Luk
ir@invitae.com 

Amy Sands Hadsock
pr@invitae.com 

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/invitae-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-tuesday-february-28-2023-301745488.html

SOURCE Invitae Corporation

Investor Contact

Christin O’Donnell
VP, Investor Relations
Laboratory Corporation of America Holdings
531 South Spring Street
Burlington, NC 27215
336-436-5076
investor@labcorp.com